Vasopressin effectively suppresses male fertility.

Arginine vasopressin (VP) is neurohypophysial hormone has been implicated in stimulating contractile activity of the male reproductive tract in the testis. Higher levels of VP decrease sperm count and motility. However, very little is known about the involvement of VP in controlling mammalian reprod...

Full description

Bibliographic Details
Main Authors: Woo-Sung Kwon, Yoo-Jin Park, Yun-Hee Kim, Young-Ah You, In Cheul Kim, Myung-Geol Pang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3554711?pdf=render
id doaj-f24f2afb94f34f898f3cb0cd76cf92fa
record_format Article
spelling doaj-f24f2afb94f34f898f3cb0cd76cf92fa2020-11-25T01:22:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0181e5419210.1371/journal.pone.0054192Vasopressin effectively suppresses male fertility.Woo-Sung KwonYoo-Jin ParkYun-Hee KimYoung-Ah YouIn Cheul KimMyung-Geol PangArginine vasopressin (VP) is neurohypophysial hormone has been implicated in stimulating contractile activity of the male reproductive tract in the testis. Higher levels of VP decrease sperm count and motility. However, very little is known about the involvement of VP in controlling mammalian reproductive process. The goal of this study was to confirm that effect of VP receptor (AVPR2) on sperm function in capacitation condition. Deamino [Cys 1, D-ArgS] vasopressin (dDAVP), an AVPR2 agonist that operates only on AVPR2, was used. Also, Mouse spermatozoa were incubated with various concentrations of dDAVP (10(-11)-10(-5) M) and sperm motility, capacitation status, Protein Kinase A activity (PKA), tyrosine phosphorylation, fertilization, and embryo development were assessed using computer-assisted sperm analysis, Combined Hoechst 33258/chlortetracycline fluorescence, Western blotting, and in vitro fertilization, respectively. AVPR2 was placed on the acrosome region and mid-piece in cauda epididymal spermatozoa, but the caput epididymal spermatozoa was mid-piece only. The high dDAVP treatment (10(-8) and 10(-5) M) significantly decreased sperm motility, intracellular pH and PKA substrates (approximately 55 and 22 kDa) and increased Ca(2+) concentration. The highest concentration treatment significantly decreased PKA substrate (approximately 23 kDa) and tyrosine phosphorylation (approximately 30 kDa). VP detrimentally affected capacitation, acrosome reaction, and embryo development. Treatment with the lowest concentration (10(-11) M) was not significantly different. Our data have shown that VP stimulates ion transport across sperm membrane through interactions with AVPR2. VP has a detrimental effect in sperm function, fertilization, and embryonic development, suggesting its critical role in the acquisition of fertilizing ability of mouse spermatozoa. These research findings will enable further study to determine molecular mechanism associated with fertility in capacitation and fertilization. It is also an important pivotal precondition to the progress of diagnostic test to identify infertility and to apply male contraception.http://europepmc.org/articles/PMC3554711?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Woo-Sung Kwon
Yoo-Jin Park
Yun-Hee Kim
Young-Ah You
In Cheul Kim
Myung-Geol Pang
spellingShingle Woo-Sung Kwon
Yoo-Jin Park
Yun-Hee Kim
Young-Ah You
In Cheul Kim
Myung-Geol Pang
Vasopressin effectively suppresses male fertility.
PLoS ONE
author_facet Woo-Sung Kwon
Yoo-Jin Park
Yun-Hee Kim
Young-Ah You
In Cheul Kim
Myung-Geol Pang
author_sort Woo-Sung Kwon
title Vasopressin effectively suppresses male fertility.
title_short Vasopressin effectively suppresses male fertility.
title_full Vasopressin effectively suppresses male fertility.
title_fullStr Vasopressin effectively suppresses male fertility.
title_full_unstemmed Vasopressin effectively suppresses male fertility.
title_sort vasopressin effectively suppresses male fertility.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description Arginine vasopressin (VP) is neurohypophysial hormone has been implicated in stimulating contractile activity of the male reproductive tract in the testis. Higher levels of VP decrease sperm count and motility. However, very little is known about the involvement of VP in controlling mammalian reproductive process. The goal of this study was to confirm that effect of VP receptor (AVPR2) on sperm function in capacitation condition. Deamino [Cys 1, D-ArgS] vasopressin (dDAVP), an AVPR2 agonist that operates only on AVPR2, was used. Also, Mouse spermatozoa were incubated with various concentrations of dDAVP (10(-11)-10(-5) M) and sperm motility, capacitation status, Protein Kinase A activity (PKA), tyrosine phosphorylation, fertilization, and embryo development were assessed using computer-assisted sperm analysis, Combined Hoechst 33258/chlortetracycline fluorescence, Western blotting, and in vitro fertilization, respectively. AVPR2 was placed on the acrosome region and mid-piece in cauda epididymal spermatozoa, but the caput epididymal spermatozoa was mid-piece only. The high dDAVP treatment (10(-8) and 10(-5) M) significantly decreased sperm motility, intracellular pH and PKA substrates (approximately 55 and 22 kDa) and increased Ca(2+) concentration. The highest concentration treatment significantly decreased PKA substrate (approximately 23 kDa) and tyrosine phosphorylation (approximately 30 kDa). VP detrimentally affected capacitation, acrosome reaction, and embryo development. Treatment with the lowest concentration (10(-11) M) was not significantly different. Our data have shown that VP stimulates ion transport across sperm membrane through interactions with AVPR2. VP has a detrimental effect in sperm function, fertilization, and embryonic development, suggesting its critical role in the acquisition of fertilizing ability of mouse spermatozoa. These research findings will enable further study to determine molecular mechanism associated with fertility in capacitation and fertilization. It is also an important pivotal precondition to the progress of diagnostic test to identify infertility and to apply male contraception.
url http://europepmc.org/articles/PMC3554711?pdf=render
work_keys_str_mv AT woosungkwon vasopressineffectivelysuppressesmalefertility
AT yoojinpark vasopressineffectivelysuppressesmalefertility
AT yunheekim vasopressineffectivelysuppressesmalefertility
AT youngahyou vasopressineffectivelysuppressesmalefertility
AT incheulkim vasopressineffectivelysuppressesmalefertility
AT myunggeolpang vasopressineffectivelysuppressesmalefertility
_version_ 1725125724182937600